Matinas BioPharma Holdings Inc MTNB

US Biotechnology

$0.29 ▼ -7.44% ($-0.02)

⬇️ Below Yest. Low 🎈 Low Float 🗓️ Earnings Next Week

Open $0.32

Prev Close $0.32

Day Range $0.28 – $0.32

52W Range $0.23 – $3.09

Market Cap $4.02M

Beta 1.74

EPS (TTM) $-1.62

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NYSE MKT LLC
Currency	USD
IPO Date	2014-06-03
Shares Out.	13,690,000
Website	matinasbiopharma.com/ ↗
Phone	13026365400
Employees	2
Net Income	-$1.9M
Total Assets	$5.9M
Total Liabilities	$2.9M
Equity	$3.0M

About Matinas BioPharma Holdings Inc

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.

Matinas BioPharma Holdings Inc is a publicly traded company under the ticker symbol MTNB on the NYSE MKT LLC, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.